Factors associated with relapse after bone marrow transplantation for myelodysplasia in multivariate analysis
| Variables . | Relative risk (95% CI) . | P . |
|---|---|---|
| Blasts in bone marrow before transplantation4-150 | ||
| (1) Less than 5% | 1.00 | P‡overall < .0001 |
| (2) 5%-20% | 2.9 (1.7-4.9) | P12 < .0001 |
| (3) More than 20% | 6.3 (3.4-11.6) | P13 < .0001 |
| (4) Unknown | 2.5 (1.3-4.9) | P140 = .0082 |
| IPSS at diagnosis4-153 | ||
| (1) High risk | 1.00 | |
| (2) Intermediate/low risk | 0.5 (0.3-0.8) | P12 = .0061 |
| (3) Unknown | 0.4 (0.2-0.7) | P13 = .0033 |
| GVHD prophylaxis | ||
| (1) Non T-cell depletion | 1.00 | |
| (2) T-cell depletion | 1.8 (1.0-3.2) | P = .0361 |
| Variables . | Relative risk (95% CI) . | P . |
|---|---|---|
| Blasts in bone marrow before transplantation4-150 | ||
| (1) Less than 5% | 1.00 | P‡overall < .0001 |
| (2) 5%-20% | 2.9 (1.7-4.9) | P12 < .0001 |
| (3) More than 20% | 6.3 (3.4-11.6) | P13 < .0001 |
| (4) Unknown | 2.5 (1.3-4.9) | P140 = .0082 |
| IPSS at diagnosis4-153 | ||
| (1) High risk | 1.00 | |
| (2) Intermediate/low risk | 0.5 (0.3-0.8) | P12 = .0061 |
| (3) Unknown | 0.4 (0.2-0.7) | P13 = .0033 |
| GVHD prophylaxis | ||
| (1) Non T-cell depletion | 1.00 | |
| (2) T-cell depletion | 1.8 (1.0-3.2) | P = .0361 |